W54 - CVD Biomarkers for 2010-2015 (SHARe cohort only)

Investigator Names and Contact Information

Introduction/Intent

To measure glucose, insulin, fasting lipid profile (total cholesterol, triglycerides, HDL and calculated LDL), CRP and creatinine in baseline bloods from the WHI SHARe cohort. The WHI SHARe cohort includes approximately 8,515 self-identified African American women and 3,642 Hispanic women who provided consent for DNA analysis.

W54 becomes part of a set of Core Studies that provide both GWAS and Biomarker data on approximately 22,000 women: 8,815 African Americans, 3,642 Hispanics, and 10,260 selected European Americans (EA) in the Hormone Trial (HT). Note that not all cases in M13-GARNET have corresponding biomarkers.

GWAS1

Study IDDescription#3
M5 - SHARe8,515 Black + 3,641 Hispanic12,007
M13 - GARNET4HT with CHD, stroke, VTE, diabetes, and matching controls (excludes those in SHARe; includes 1,400 from WHIMS)4,684
W63 - WHIMS+WHIMS (excludes 1,400 EA HT in GARNET)4,661
W63 - WHIMS+not GARNET, not WHIMS61,178

Biomarkers2

Study IDDescription#3
W54 - SHARe CVD BiomarkersSame as M5-SHARe12,007
W58 - EA HT BiomarkersAll GARNET controls plus random selection of GARNET cases5 (excludes all WHIMS)3,067
"All WHIMS (includes 1,400 from GARNET and 4,661 from WHIMS+)6,061
"not GARNET, not WHIMS61,178

1 - dbGaP eligible

2 - insulin, glucose, CRP, creatinine, cholesterol, HDL, LDL, triglyceride

3 - Approximate number of sample results

4 - Number of participants with GWAS is about 5,060; not all cases had CVD biomarkers done in W58.

5 - Not all participants with GWAS in M13-GARNET have biomarkers; instead the 'not GARNET, not WHIMS' participants were added.

6 - Random selection of HT participants by age was added to provide a more balanced cross-section of HT participants

Results

Biomarkers were tested at the Advanced Research and Diagnostic Lab at the University of Minnesota (assay metho​dologies)

Data available on this site Here.

Publications:

See publications: WHI publications by study lists published WHI papers that have been generated by ancillary studies. A complete list of WHI papers is available in the Papers of this website.

Related Papers

APOB and NPC1L1 gene-by-environment interactions affecting dietary cholesterol absorption and total cholesterol levels: results from the Women’s Health Initiative

Approved Proposal, Kim, Daniel Seung et al., 2014/12 MSID: 2611
Related Studies: M24, W54, W58

Dietary Inflammatory Potential and the Risk of Incident Kidney Failure in the Women’s Health Initiative

Approved Manuscript, Johns, Tanya et al., 2024/9 MSID: 3842
Keywords: Diet; Inflammation; End-Stage Renal Disease; Chronic Kidney Disease; Racial Disparities; Aging
Related Studies: 422, W35, W54, W58, W66

Cardiovascular risk prediction in women with and without chronic kidney disease

Approved Manuscript, Gallo, Robert et al., 2023/10 MSID: 4306
Keywords: Chronic Kidney Disease; Risk Prediction; Cardiovascular Disease; Risk Modeling; Primary Prevention
Related Studies: W54, W58

Leveraging population admixture to characterize the heritability of complex traits

Noah Zaitlen et al., 2014/11 PubMed #25383972 MSID: 1872
Despite recent progress on estimating the heritability explained by genotyped SNPs (h(2)g), a large gap between h(2)g and estimates of total narrow-sense heritability (h(2)) remains. Explanations for this gap include rare variants or upward bias in family-based estimates of h(2) due to shared environment or epistasis. We estimate h(2) from unrelated individuals in admixed populations by first estimating the heritability explained by local ancestry (h(2)?). We show that h(2)? = 2FSTC?(1 - ?)h(2),...
Keywords: Genetics; Gwas; Heritability; Cardiovascular; Metabolic
Related Studies: M5, W54

Insulin level and risk of non-Hodgkin lymphoma among postmenopausal women in The Women’s Health Initiative

Approved Proposal, Peila, Rita et al., 2016/11 MSID: 3202
Keywords: Insulin; Type 2 Diabetes; Inflammation; C-Reactive Protein; Non-Hodgkin Lymphoma

Relation of pregnancy loss to risk of cardiovascular disease in parous postmenopausal women (from the Women’s Health Initiative)

Philip Hall et al., 2019/2 PubMed #30871746 MSID: 3204
Women with history of pregnancy loss (PL) have higher burden of cardiovascular disease (CVD) later in life, yet it is unclear whether this is attributable to an association with established CVD risk factors (RFs). We examined whether PL is associated with CVD RFs and biomarkers in parous postmenopausal women in the Women's Health Initiative, and whether the association between PL and CVD RFs accounted for the association between PL and incident CVD. Linear and logistic regressions were used to e...
Keywords: Pregnancy Loss; Cardiovascular Risk Factors; Inflammatory Biomarkers; Hemostatic Biomarkers; Diabetes
Related Studies: W1, W54, W58

Social relationships, inflammation markers, and breast cancer incidence in the Women's Health Initiative

Evan Busch et al., 2018/3 PubMed #29614476 MSID: 2272
OBJECTIVES: Previous research has reported associations between social relationships and carcinogenesis. Inflammation is a potential mediator of these associations. To clarify these links for one tumor site, we examined associations between social relationships, circulating inflammation markers, and breast cancer incidence. MATERIALS AND METHODS: Among 132,262 participants from the prospective Women's Health Initiative, we used linear and logistic regression to evaluate associations between soci...
Keywords: Breast Cancer; Etiology; Incidence; Inflammation; Mediation; Social Relationship Characteristics
Related Studies: W54, W58

Adiposity, history of diabetes, and risk of pancreatic cancer in postmenopausal women

Rhonda Arthur et al., 2018/9 PubMed #30449532 MSID: 3447
PURPOSE: The purpose of this study was to examine the association of type II diabetes and anthropometric variables with risk of pancreatic cancer among postmenopausal women. METHODS: Weight, height, waist circumference, and hip circumference were measured by trained personnel, whereas history of diabetes and weight earlier in life were self-reported. Pancreatic cancer was ascertained via central review of medical records by physician adjudicators. After exclusions, 1045 cases of pancreatic cance...
Keywords: Adiposity; Body Mass Index; Waist Circumference; Waist-Hip Ratio; Serum Insulin; Pancreatic Cancer; Postmenopausal Women
Related Studies: W54, W58, W66

Metabolic obesity phenotype, age acceleration and obesity-related cancer risk in the Women’s Health Initiative

Approved Proposal, Karra, Prasoona et al., 2023/3 MSID: 4878
Keywords: Obesity-Associated Cancer; Metabolic Dysfunction; Body Mass Index; Metabolic Health Phenotypes; Age Acceleration
Related Studies: 311, 315, 564, BA23, W1, W2, W54, W58, W66

Kidney stones and the risk of chronic kidney disease among postmenopausal women: Results from The Women's Health Initiative

Approved Proposal, Javadi, Mahsa et al., 2024/2 MSID: 5020
Keywords: Urinary Tract Stones; Chronic Kidney Disease; End-Stage Kidney Disease (Eskd); Mortality; Hazard Ratio; Postmenopausal Women
Related Studies: 422, M5, M13, W54, W58, W64, W66

The influence of vasomotor symptoms, age, and cardiometabolic status on effects of menopausal hormone therapy on cardiovascular disease: the Women’s Health Initiative Randomized Clinical Trials

Approved Manuscript, Rossouw, Jacques et al., 2024/9 MSID: 4962
Keywords: Coronary Heart Disease; Vasomotor Symptoms; Hormone Therapy; Lipids; Metabolic Syndrome; Stroke; All-Cause Mortality
Related Studies: 422, W1, W6, W11, W54, W58

10-Year risk of atherosclerotic cardiovascular disease, hormone Therapy and cardiovascular disease outcomes in the Women’s Health Initiative hormone therapy trial

Approved Proposal, Nudy, Matthew et al., 2024/4 MSID: 5101
Keywords: Hormone Therapy; Cardiovascular Disease Risk; Pooled Cohort Equation; Coronary Heart Disease; Stroke
Related Studies: 422, W1, W6, W54, W58

Genetic ancestry and Lp(a) concentrations in menopausal women: a secondary analysis of the Women’s Health Initiative hormone therapy clinical trial

Approved Proposal, Nudy, Matthew et al., 2024/11 MSID: 5227
Keywords: Hormone Therapy; Estrogen; Estrogen Plus Progestin; Lipid; Glucose; Insulin; Biomarkers
Related Studies: W1, W54